Subscribe   RSS Contact Us

Holcombe’s E&C Testimony: PDUFA VI Will Take Patient-focused Drug Development to New Level

March 23, 2017 – In testimony before the House Energy and Commerce Committee’s Subcommittee on Health yesterday, Biotechnology Industry Organization ... read more

Gottlieb Is “Known” Entity to Pharma Industry

March 20, 2017 – Although medical marketers are very familiar with Scott Gottlieb, President Donald Trump’s choice for the top ... read more

Industry Groups Oppose Oregon Bill Calling for Advertising Price Disclosure

March 9, 2017 – Four major advertising and media industry groups have issued a joint letter opposing an Oregon bill ... read more

Trump Needs to Take a Closer Look at FDA Performance

March 8, 2017 – In an open letter to President Donald Trump, Pharmalot’s Ed Silverman asks that before Trump criticizes ... read more

Industry Peacekeeping with President Trump Holds Promise But Portends Danger

By John Kamp, Executive Director, Coalition for Healthcare Communication [Editor’s Note: This “The Final Word” column appeared in the February ... read more

Citizen Petition Calls on FDA to Stay Final Rule Establishing “Totality of the Evidence” Standard for Intended Use

Feb. 24, 2017 – The FDA recently published a final rule on intended use and adequate directions for use that ... read more

Previous Next

Coalition and AAAA Publish Joint FDA Social Media Testimony

At the November 12th FDA Public Hearing on “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools,” John Kamp, the Coalition’s Executive Director,  presented testimony on behalf of the Coalition and the American Association of Advertising Agencies. The testimony offers FDA a regulatory pathway to advance the public health by enabling robust marketing by regulated companies and at the same time coordinating effective enforcement against health fraud on the Internet. The Coalition/AAAA presentation was delivered early on the 1st day of the hearing and lay the groundwork for testimony by other industry leaders.

Topics discussed in the slide presentation include:

  • Problems involved with providing accurate healthcare information in social media
  • How social media can be used to better inform the public
  • What is needed to create a new mindset for the role of FDA-regulated information

View the slide presentation

We invite your comments!

User Comments 1

  1. “At the November 12th FDA Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools, John Kamp, the Coalition’s Executive Director, will present testimony on behalf of the Coalition and the American Association of Advertising Agencies. The testimony offers FDA a regulatory pathway to advance the public health by enabling robust marketing by regulated companies and at the same time coordinating effective enforcement against health fraud on the Internet. The Coalition/AAAA presentation will be delivered early on the 1st day of the hearing and lay the groundwork for testimony by other industry leaders.”
    – absolutely agree to this post! Very good job and keep it up!
    -Bob
    seo services

    gm0nk3y on Jan 18, 2010 @ 3:24PM